What are r AHA/ACC guidelines for athletic competition by persons with long QT syndrome (LQTS)?

Updated: Nov 29, 2017
  • Author: Ali A Sovari, MD, FACP, FACC; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print

A scientific statement published in 2015 by the AHA/ACC on athletic competition by persons with known or suspected cardiac channelopathies includes the following recommendations related to LQTS [40] :

  • That a heart rhythm specialist or genetic cardiologist experienced in cardiac channelopathies conduct a thorough evaluation of an athlete in whom such a disorder has been diagnosed or is suspected
  • That asymptomatic athletes who are genotype-positive/phenotype-negative for LQTS, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, early repolarization syndrome, short-QT syndrome, or idiopathic ventricular fibrillation be allowed to take part in all competitive sports if precautionary measures, such as the avoidance of QT-prolonging drugs, are undertaken
  • That an athlete who is symptomatic for LQTS or in whom it can be found electrocardiographically be considered for competitive sports (with the exception of competitive swimming, if the athlete is a previously symptomatic LQT1 host) if precautionary measures have been undertaken, treatment is being administered, and the person has been asymptomatic on therapy for at least 3 months (although treatment involving an ICD is subject to additional recommendations)

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!